Metabolic Syndrome Clinical Trial
Official title:
Association Between Periodontitis and Adverse Pregnancy Outcomes in Metabolic Syndrome Patients- Interventional Study
Aim The Aim of the current study is to establish the association between periodontitis and
adverse pregnancy outcomes in metabolic syndrome (Mets) patients and to evaluate the effect
of intervention.
Objectives
1. To evaluate the changes in periodontal status of pregnant women with metabolic syndrome
after non surgical periodontal therapy (NSPT)
2. To evaluate the inflammatory marker levels in serum of pregnant women with metabolic
syndrome after non surgical periodontal therapy
3. To evaluate the effect of NSPT on adverse pregnancy outcomes of women with metabolic
syndrome
Research Design/Methodology Ethics approval will be obtained from Institution Review Board of
Riyadh Colleges of Dentistry and Pharmacy.
Sample size calculation (Green, 1991) By considering the Green's formula as below; Medium
effect size (R2=0.07) variance in dependent variable accounted for by the independent
variable. Beta weights of (ß=0.20). N≥104+k (Number of independent variable) .Hence total
sample size required by considering 8 independent variables will be N=104+8=112. Expecting a
patient drop out rate of 30%, the sample size is being increased to 50 patients per group.
Approximately 150 patients will be recruited from maternity hospitals of Riyadh City.
Written informed consent will be obtained from patients after explaining the details of the
study. Patients will be evaluated using a detailed questionnaire. Demographic characteristics
such as age, diet, medical history etc will be recorded. All participants will be interviewed
by principal investigator at each visit to capture oral hygiene knowledge and behaviors and
exposure to risk factors for adverse pregnancy outcomes. Reviews of medical records will be
conducted by principal investigator to record pregnancy history, document the course of the
current pregnancy, and record any adverse events. All patients will be advised to report
immediately to our dental clinic in case they have any dental related issues during the study
period.
Examination Procedure All dental examinations will be performed by principal investigator.
Clinical oral examinations will record number of teeth, the number of filled and carious
teeth.
Outcome Measures: Periodontal parameters: Gingival Index, Plaque Index, Bleeding on probing,
Probing depth (PD), Clinical attachment loss (CAL)
A complete periodontal examination will be conducted with the following assessments:
Bleeding on probing, Probing depth and clinical attachment level will be evaluated at six
sites per tooth, whereas plaque index and gingival index will be evaluated at four sites per
tooth.
Gingival index (GI). All teeth except third molars will be evaluated for gingival inflammation
using a modification of the Loe and Silness , 1963 GI. The GI uses the following scores: 0 =
normal gingiva; 1 = mild inflammation; 2 = moderate inflammation; and 3 = severe inflammation.
Plaque index (PI). Prebrushing plaque scores for the buccal surface of each tooth will be
assigned using a zero to three scale (Silness and Loe, 1964 ) PI, with ''0''indicating an
absence of plaque on the clinical crown and a ''3'' indicating the presence of soft deposits
covering more than two-thirds of the crown.
Bleeding on probing (BOP). BOP will be assessed during and recorded after probing measures
will be taken for each quadrant. The scoring will be as follows:
0 = absence of bleeding; 1 = bleeding present.
Probing depth. and gingival recession .A manual periodontal probe University of North
Carolina -15 probe (UNC-15) , Hu-Friedy, Chicago, Illinois ,will be used to record on all
teeth present in the mouth.
Probing depth will be calculated from gingival margin to base of pocket. CAL will be
calculated using the clinically detectable cemento-enamel junction (CEJ) as reference and it
will be measured from CEJ to base of pocket.
Case definition of Periodontitis outlined by Page & Eke (2007) will be used. The case
definition for severe periodontitis requires two or more interproximal sites with CAL > 6 mm,
not on the same tooth, and one or more interproximal sites with PD >5 mm. Moderate
periodontitis is defined as two or more interproximal sites with CAL >4 mm, not on the same
tooth, or two or more interproximal sites with PD >5 mm, not on the same tooth.
Adult Treatment Panel (ATP) III criteria for Mets will be met if an individual has three or
more of the following components (Dos Prazeres Tavares et al, 2016):
Abdominal obesity: waist circumference >88 cm (35 inches) in women; Pregestation Body mass
index (BMI) > 30kg/m2 High fasting glucose (FPG): serum glucose level > 110 mg/dl (6.1
mmol/l) or on treatment for diabetes; High blood pressure (BP): systolic BP >130 mm Hg and/or
diastolic BP >85 mm Hg or on treatment for hypertension (HTN) Hypertriglyceridemia: serum
triglyceride level >150 mg/dl (1.69 mmol/l); and Low high-density lipoprotein (HDL)
cholesterol: Serum HDL cholesterol <50 mg/dl (1.29 mmol/l) in women.
Clinical data and samples of blood will be collected at three intervals
- At baseline (before 20 weeks gestation)
- 8 weeks after completion of periodontal therapy
- Within 1-2 days of delivery
Serum bio markers: Interleukin-6(IL-6), Prostaglandin-E2 (PG-E2)
Pregnancy Outcomes: Preterm birth < 37 weeks, Low birth weight < 2500 gms, Preterm low birth
weight.
The patients and technicians who will perform the lab analyses will be blinded to group
assignment.
Study Design It is a randomized clinical trial. Group 1- Case- Periodontitis patients
undergoing Comprehensive periodontal treatment Group 2- Control- Periodontitis Patients
undergoing single visit supragingival scaling Group 3- Placebo- Patients without
Periodontitis undergoing single visit supragingival scaling After the collection of clinical
data, the participants will be randomly allocated to either groups of the study using sealed
opaque envelopes labeled with a study number and containing the group allocation. Allocations
will be computer generated by a third person who will not otherwise be involved in the study.
The Case group participants will receive non-surgical periodontal therapy that will be
completed by the end of week 20-21 of gestation. This will consist of oral hygiene
instruction with comprehensive periodontal treatment which will include excavation and
sealing of cavities, removal of overhanging restorations, extraction of hopeless teeth
followed by supragingival and subgingival scaling and root planing (SRP) of sites with PDs >
4 mm and polishing of all the teeth. Participants will be offered treatment under local
anesthetic when necessary. No limits will be imposed on the number of dental visits needed to
accomplish periodontal therapy.
The control and Placebo group participants will receive oral hygiene instruction and
supragingival cleaning of all teeth at their baseline visit. Clinical periodontal related
data will be collected at a subsequent review appointment 8 weeks after treatment for all
groups.
All control participants will be offered the opportunity to attend for comprehensive
periodontal therapy postpartum.
Blood samples will be collected after 10 hours of over night fasting. Serum triglyceride,
Serum HDL cholesterol and serum glucose will be quantified using standard laboratory
procedures in same medical laboratory for all samples collected.
A 5-ml sample of peripheral venous blood will be collected by vein puncture. The blood
samples will be centrifuged at 3000 g for 5 min and the serum will be separated. The serum
samples will be frozen in plastic vials at -20º Centigrade until further analyzing.
Commercially available ELISA assays will be used to measure concentrations of IL-6, and PGE2
in blood samples, according to the manufacturer's recommendations.
Data analysis will be done using Statistical Package for the Social Sciences (SPSS) software.
Mean and standard deviation for all clinical parameters. Differences between groups will be
assessed using independent t-tests. Sample distribution according to demographic,
socio-economic and behavioral data will be assessed using chi-square and Fisher_s exact
tests. Between-group differences on the distribution of obstetric data will be assessed using
Fisher_s exact test, and differences in adverse pregnancy outcomes will be compared using the
independent t-test. Serum bio markers will be presented as median and 25% and 75%
percentiles. Differences between groups will be assessed using the Mann- Whitney U-test, and
differences among experimental periods will be assessed using the Wilcoxon signed-rank test.
The Holm-Bonferroni method will be used to adjust for multiple comparisons. Statistical
significance will be set at 5%
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04635202 -
Effect of Elliptical Training on Metabolic Homeostasis in Metabolic Syndrome
|
N/A | |
Completed |
NCT05343858 -
Pilot Study to Evaluate the Effect of Two Microalgae Consumption on Metabolic Syndrome
|
N/A | |
Completed |
NCT04053686 -
An Intervention to Reduce Prolonged Sitting in Police Staff
|
N/A | |
Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
Recruiting |
NCT05040958 -
Carotid Atherosclerotic Plaque Load and Neck Circumference
|
||
Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
Active, not recruiting |
NCT02500147 -
Metformin for Ectopic Fat Deposition and Metabolic Markers in Polycystic Ovary Syndrome (PCOS)
|
Phase 4 | |
Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
Completed |
NCT03289897 -
Non-invasive Rapid Assessment of NAFLD Using Magnetic Resonance Imaging With LiverMultiScan
|
N/A | |
Recruiting |
NCT05956886 -
Sleep Chatbot Intervention for Emerging Black/African American Adults
|
N/A | |
Completed |
NCT06057896 -
Effects of Combined Natural Molecules on Metabolic Syndrome in Menopausal Women
|
||
Active, not recruiting |
NCT03613740 -
Effect of Fucoxanthin on the Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion
|
Phase 2 | |
Completed |
NCT04498455 -
Study of a Prebiotic Supplement to Mitigate Excessive Weight Gain Among Physicians in Residency
|
Phase 4 | |
Completed |
NCT05688917 -
Green Coffee Effect on Metabolic Syndrome
|
N/A | |
Completed |
NCT04117802 -
Effects of Maple Syrup on Gut Microbiota Diversity and Metabolic Syndrome
|
N/A | |
Completed |
NCT03697382 -
Effect of Daily Steps on Fat Metabolism
|
N/A | |
Completed |
NCT03241121 -
Study of Eating Patterns With a Smartphone App and the Effects of Time Restricted Feeding in the Metabolic Syndrome
|
N/A | |
Completed |
NCT04509206 -
Virtual Teaching Kitchen
|
N/A | |
Completed |
NCT05124847 -
TREating Pediatric Obesity
|
N/A |